PRIMARY ANTIMICROBIAL RESISTANCE OF HELICOBACTER PYLORI IN BELGIUM

REFERENCES

• Bruce MG, Maaroos HI. Epidemiology of Helicobacter pylori infection. Helico-bacter 2008; 13 (suppl): 1–6.
   Web of Science ®Google Scholar
• Malfertheiner P. Megraud F, O'Morain C et al. Management of Helicobacter pylori infection: the Maastricht IV/ Florence Consensus Report. Gut 2012; 61: 646–664.
   PubMed Web of Science ®Google Scholar
• Malfertheiner P. Megraud F, O'Morain C et al. Current concepts in the manage-ment of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007; 56: 772–781.
   PubMed Web of Science ®Google Scholar
• Mana F. The Maastricht III consensus: summary and comments. Acta Gastroen-terol BeIg 2009; 72: 344–349.
   Google Scholar
• O'Connor A, Gisbert JP, McNamara D, O'Morain C. Treatment of Helicobacter pylori infection. Helicobacter 2010; 15 (supl 1): 46–52.
   Web of Science ®Google Scholar
• Vandebosch S, Vanden Branden S. De Bel A, Urbain D, Mana F. How efficient is culture for H. pylori in daily clinical practice? Helicobacter 2009 (abstract); 14: P08.06.
   Google Scholar
• Aguemon B, Struelens M, Devière J et al. Primary antibiotic resistance and effec-tiveness of Helicobacter pylori triple therapy in ulcero-inflammatory patholo-gies of the upper digestive tract. Acta Gastroenterol Belg 2005; 68:287–293.
   PubMed Web of Science ®Google Scholar
• Glupczynski Y, Megraud F, Lopez-Brea M, Andersen LP. European Multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori. EurJ Clin Micro-biol Infect Dis 2001; 20: 820–823.
   PubMed Web of Science ®Google Scholar
• Miendje Deyi VY, Bontems P. Vandeplas J et al. Multicenter survey of routine determinations of resistance of helicobacter pylori to antimicrobials over the last 20 years (1990 to 2009) in Belgium. J Clin Microbiol 2011; 49: 2200–2209.
   PubMed Web of Science ®Google Scholar
• Bontems P. Devaster JM, Corvaglia L et al. Twelve year observation of primary and secondary antibiotic-resistant Helicobacter pylori strains in children. Pediatr Infect Dis J 2001; 20:1033–1038.
   Web of Science ®Google Scholar
• Osato M, Reddy SR, Reddy SG, Penland RL, Graham DY. Comparison of the E-test and the NCCLS-approved agar dilution method to detect metronidazole and claritromycin resistant Helicobacter pylori. Int J Antimicrob agents 2001; 17: 39–44.
   PubMed Web of Science ®Google Scholar
• Graham DY, Rimbara E. Understanding and appreciating sequential therapy for Helicobacter pylori eradication. J Clin Gastroenterol 2011; 45: 309–313.
   PubMed Web of Science ®Google Scholar
• Rimbara E, Fischbach LA, Graham DY. Optimal therapy for Helicobacter pylori infection. Nat Rev Gastroenterol Hepatol 2011; 8: 79–88.
   PubMed Web of Science ®Google Scholar
• Greenberg ER, Anderson GL, Morgan DR et al:14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial. Lancet 2011; 378(9790): 507–514.
   PubMed Web of Science ®Google Scholar
• Marshall B. Sequential therapy for Helicobacter pylori: a worthwile effort for your patients. Ann Intern Med 2008; 148: 962–996.
   PubMed Web of Science ®Google Scholar
• Bogaerts P. Berhin C, Nizet H, Glupczynski Y. Prevalence and mechanisms of resistance to fluoroquinolones in Helicobacer pylori strains from patients living in Belgium. Helicobacter 2006; 11:441–445.
   PubMed Web of Science ®Google Scholar
• Cattoir V, Nectoux J, Lascols C et al. Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility. Intern J Antimicrob Ag 2007; 29: 389–396.
   PubMed Web of Science ®Google Scholar
• Boyanova L, Nikolov R, Gergova G et al. Two-decade trends in primary Helico-bacter pylori resistance to antibiotics in Bulgaria. Diagn Microbiol Infect Dis 2010; 67: 319–326.
   PubMed Web of Science ®Google Scholar
• Boyanova L, Mitov I. Geographic map and evolution of primary helicobacter pylori resistance to antibacterial agents. Expert Rev Anti Infect Ther 2010; 8: 59–70.
   PubMed Web of Science ®Google Scholar
• De Francesco V. Margiotta M, Zullo A et al. Prevalence of primary clarithromycin resistance in Helicobacter pylori strains over a 15 year period in Italy. J Antimi-crob Chem other 2007; 59: 783–785.
   PubMed Web of Science ®Google Scholar
• Agudo S, Perez-Perez G, Alarcan T, Lopez-Brea M. High prevalence of clarithro-mycin resistant Helicobacter pylori strains and risk factors associated with resis-tance in Madrid, Spain. J Clin Microbiol 2010; 48: 3703–3707.
   PubMed Web of Science ®Google Scholar
• Bakir Ozbey S, Ozakin C, Keskin M. Antibiotic resistance rates of Helicobacter pylori isolates and the comparison of E-test and fluorescent in situ hybridization methods for the detection of clarithromycin resistant strains. Mikrobiyol Bul 2009; 43: 227–234.
   Web of Science ®Google Scholar
• Ben Mansour K, Burucoa C, Zribi M et al.Primary resistance to clarithromycin, metronidazole and amoxicillin of Helicobacter pylori isolated from Tunisian patients with peptic ulcers and gastritis: a prospective multicentre study. Ann Clin Microbiol Antimicrob 2010; 9:22.
   PubMed Web of Science ®Google Scholar
• Loffeld R, Fijen C. Antibiotic resistance of Helicobacter pylori: a cross-sectional study in consecutive patients, and relation to ethnicity. Clin Microbiol Infect 2003; 9: 600–604.
   Web of Science ®Google Scholar
• Mégraud F. H.pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 2004; 53: 1374–1384.
   PubMed Web of Science ®Google Scholar
• Karabay O, Hosoglu S. Increased antimicrobial consumption following reim-bursement reform in Turkey. J Antimicrob Chemother 2008; 61: 1169–1171.
   PubMed Web of Science ®Google Scholar
• Chisholm SA, Teare EL, Davies K, Owen RJ. Surveillance of primary antibiotic resistance of Helicobacter pylori at centres in England and Wales over a six-year period (2000-2005). Euro Suryeill 2007; 12: E3–E4.
   Google Scholar
• Osato MS, Reddy R, Reddy SG, Penland RL, Malaty HM, Graham DY. Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States. Arch Intern Med 2001; 161: 1217–1220.
   PubMed Web of Science ®Google Scholar